EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Neuserine was filed as Word mark on 07/05/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/07/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 017926761 |
| Application date | July 5, 2018 |
| Publication date | August 10, 2018 |
| Entry date | December 7, 2020 |
| Expiration date | July 5, 2028 |
Trademark owner
20F.-10, No.99, Sec. 1, Xintai 5th Rd., Xizhi Dist.
221 New Taipei City
TW
221 New Taipei City
TW
Trademark representatives
Ingolstädter Str. 5
80807 München
DE
Objection / Complaint
10/25/2018: Likelihood of confusion
Applicant
LABORATORIOS DEITERS, S.L.
10/31/2018: Likelihood of confusion
Unfair advantage /detriment to distinctiveness or repute
Applicant
Beiersdorf AG
goods and services
5
chemical preparations for pharmaceutical purposes for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for medical purposes for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for veterinary purposes excluding chemical preparations for use in skin care products for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for human purposes for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for veterinary purposes excluding medicines for use in skin care products for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceuticals for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pre-filled syringes for medical purposes for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; none of these goods for the treatment of nausea, vomiting and/or dizziness
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 11, 2018 | Change Representative, Registered |
ID: 11017926761